

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac myofibril assembly (GO:0055003) | 6.08436621 |
| 2 | sarcomere organization (GO:0045214) | 5.92597286 |
| 3 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.91013295 |
| 4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.78647839 |
| 5 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.67376199 |
| 6 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.65066021 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.48961470 |
| 8 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.46585412 |
| 9 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.27667144 |
| 10 | cardiac muscle contraction (GO:0060048) | 5.14009366 |
| 11 | myofibril assembly (GO:0030239) | 5.13720936 |
| 12 | plasma membrane repair (GO:0001778) | 5.05168331 |
| 13 | cell communication by electrical coupling (GO:0010644) | 4.98453303 |
| 14 | cell communication involved in cardiac conduction (GO:0086065) | 4.84572606 |
| 15 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.74687528 |
| 16 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.50651928 |
| 17 | regulation of actin filament-based movement (GO:1903115) | 4.48446227 |
| 18 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.44944532 |
| 19 | regulation of membrane repolarization (GO:0060306) | 4.38974657 |
| 20 | tricarboxylic acid cycle (GO:0006099) | 4.32000872 |
| 21 | cardiac muscle cell development (GO:0055013) | 4.15533822 |
| 22 | detection of calcium ion (GO:0005513) | 4.13035285 |
| 23 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.12850293 |
| 24 | cardiac muscle hypertrophy (GO:0003300) | 4.06626650 |
| 25 | regulation of cell communication by electrical coupling (GO:0010649) | 4.03836294 |
| 26 | skeletal muscle contraction (GO:0003009) | 4.01885575 |
| 27 | muscle filament sliding (GO:0030049) | 4.00135995 |
| 28 | actin-myosin filament sliding (GO:0033275) | 4.00135995 |
| 29 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.99342103 |
| 30 | regulation of relaxation of muscle (GO:1901077) | 3.97893997 |
| 31 | actomyosin structure organization (GO:0031032) | 3.97406734 |
| 32 | cardiac cell development (GO:0055006) | 3.86836585 |
| 33 | striated muscle hypertrophy (GO:0014897) | 3.86199523 |
| 34 | adult heart development (GO:0007512) | 3.84233869 |
| 35 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.81795008 |
| 36 | striated muscle contraction (GO:0006941) | 3.80949644 |
| 37 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.77385502 |
| 38 | regulation of striated muscle contraction (GO:0006942) | 3.77136774 |
| 39 | regulation of sarcomere organization (GO:0060297) | 3.69307891 |
| 40 | cardiac conduction (GO:0061337) | 3.64235138 |
| 41 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.58345971 |
| 42 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.57915700 |
| 43 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.57038202 |
| 44 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.55899539 |
| 45 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.55899539 |
| 46 | desmosome organization (GO:0002934) | 3.54086461 |
| 47 | heart trabecula formation (GO:0060347) | 3.50827704 |
| 48 | regulation of cardiac muscle contraction (GO:0055117) | 3.49932867 |
| 49 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.49928923 |
| 50 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.48693001 |
| 51 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.48553462 |
| 52 | cell-substrate adherens junction assembly (GO:0007045) | 3.46413753 |
| 53 | focal adhesion assembly (GO:0048041) | 3.46413753 |
| 54 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.45432659 |
| 55 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.45023870 |
| 56 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.43423023 |
| 57 | potassium ion import (GO:0010107) | 3.43398514 |
| 58 | cardiac muscle cell action potential (GO:0086001) | 3.42508698 |
| 59 | carnitine shuttle (GO:0006853) | 3.39804290 |
| 60 | * regulation of the force of heart contraction (GO:0002026) | 3.39466156 |
| 61 | creatine metabolic process (GO:0006600) | 3.38370433 |
| 62 | response to inactivity (GO:0014854) | 3.36303341 |
| 63 | negative regulation of potassium ion transport (GO:0043267) | 3.36038214 |
| 64 | membrane repolarization during action potential (GO:0086011) | 3.35622113 |
| 65 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.35225966 |
| 66 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.34094826 |
| 67 | sodium ion export (GO:0071436) | 3.33205657 |
| 68 | adherens junction assembly (GO:0034333) | 3.32739799 |
| 69 | actin-mediated cell contraction (GO:0070252) | 3.31524185 |
| 70 | activation of protein kinase A activity (GO:0034199) | 3.30758929 |
| 71 | muscle hypertrophy (GO:0014896) | 3.30332964 |
| 72 | positive regulation of cation channel activity (GO:2001259) | 3.30253003 |
| 73 | cell-substrate junction assembly (GO:0007044) | 3.29749024 |
| 74 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.29710979 |
| 75 | muscle contraction (GO:0006936) | 3.27959298 |
| 76 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.26491282 |
| 77 | hemidesmosome assembly (GO:0031581) | 3.18272853 |
| 78 | membrane repolarization (GO:0086009) | 3.15543566 |
| 79 | * relaxation of cardiac muscle (GO:0055119) | 3.15119430 |
| 80 | regulation of skeletal muscle contraction (GO:0014819) | 3.14286098 |
| 81 | * regulation of heart rate (GO:0002027) | 3.12158165 |
| 82 | muscle tissue morphogenesis (GO:0060415) | 3.11108272 |
| 83 | regulation of synapse structural plasticity (GO:0051823) | 3.10148838 |
| 84 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.07521714 |
| 85 | regulation of cofactor metabolic process (GO:0051193) | 3.06073618 |
| 86 | regulation of coenzyme metabolic process (GO:0051196) | 3.06073618 |
| 87 | muscle hypertrophy in response to stress (GO:0003299) | 3.05371739 |
| 88 | cardiac muscle adaptation (GO:0014887) | 3.05371739 |
| 89 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.05371739 |
| 90 | * regulation of heart contraction (GO:0008016) | 3.04410437 |
| 91 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.04049202 |
| 92 | regulation of potassium ion transmembrane transport (GO:1901379) | 3.03881969 |
| 93 | positive regulation of potassium ion transport (GO:0043268) | 3.03499804 |
| 94 | striated muscle adaptation (GO:0014888) | 3.02810146 |
| 95 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.01765014 |
| 96 | growth hormone secretion (GO:0030252) | 2.98632857 |
| 97 | synaptic vesicle maturation (GO:0016188) | 2.98583311 |
| 98 | locomotory exploration behavior (GO:0035641) | 2.98102474 |
| 99 | * sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.97587019 |
| 100 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.95105998 |
| 101 | response to muscle activity (GO:0014850) | 2.92541799 |
| 102 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.92374296 |
| 103 | regulation of cation channel activity (GO:2001257) | 2.91552097 |
| 104 | positive regulation of myotube differentiation (GO:0010831) | 2.90971550 |
| 105 | * muscle system process (GO:0003012) | 2.88820866 |
| 106 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.86687229 |
| 107 | fatty acid transmembrane transport (GO:1902001) | 2.85102003 |
| 108 | NADH metabolic process (GO:0006734) | 2.84267596 |
| 109 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.80627688 |
| 110 | negative regulation of protein localization to cell surface (GO:2000009) | 2.79893417 |
| 111 | cellular potassium ion homeostasis (GO:0030007) | 2.79560677 |
| 112 | epithelial cell-cell adhesion (GO:0090136) | 2.79243036 |
| 113 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 2.76254050 |
| 114 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.75791117 |
| 115 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.75791117 |
| 116 | positive regulation of sodium ion transport (GO:0010765) | 2.69568997 |
| 117 | membrane depolarization during action potential (GO:0086010) | 2.67220178 |
| 118 | actin filament-based movement (GO:0030048) | 2.66573392 |
| 119 | regulation of cardioblast differentiation (GO:0051890) | 2.65137623 |
| 120 | multicellular organismal signaling (GO:0035637) | 2.64850827 |
| 121 | skeletal muscle adaptation (GO:0043501) | 2.61509176 |
| 122 | cellular sodium ion homeostasis (GO:0006883) | 2.54035064 |
| 123 | skeletal muscle fiber development (GO:0048741) | 2.52179921 |
| 124 | muscle cell cellular homeostasis (GO:0046716) | 2.51231086 |
| 125 | cellular response to epinephrine stimulus (GO:0071872) | 2.49847420 |
| 126 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.44888297 |
| 127 | myoblast fusion (GO:0007520) | 2.44340234 |
| 128 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.42677327 |
| 129 | atrioventricular valve morphogenesis (GO:0003181) | 2.41673397 |
| 130 | cerebellar granule cell differentiation (GO:0021707) | 2.41560412 |
| 131 | myotube differentiation (GO:0014902) | 2.41347628 |
| 132 | striated muscle cell development (GO:0055002) | 2.41265585 |
| 133 | negative regulation of cell size (GO:0045792) | 2.40298807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.86231218 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.71960249 |
| 3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.86345827 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.45511504 |
| 5 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.44230634 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.43708891 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.40884704 |
| 8 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.35621232 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.19292648 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.18391004 |
| 11 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.04361074 |
| 12 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.04361074 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.03052338 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.03052338 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.02055739 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.97281240 |
| 17 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.90347530 |
| 18 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.89497678 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.89453003 |
| 20 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.83577008 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.83473466 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.80930667 |
| 23 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.80786398 |
| 24 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.75504289 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.71950078 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.69532943 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.68811423 |
| 28 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.68275279 |
| 29 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.67527334 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.66449736 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.65914876 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65766698 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.65645176 |
| 34 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.65309695 |
| 35 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.63569187 |
| 36 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.62939221 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.62132397 |
| 38 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.61015432 |
| 39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.59523486 |
| 40 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.58445320 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57958396 |
| 42 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.54192529 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.53906020 |
| 44 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.53390128 |
| 45 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.53330304 |
| 46 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.51460589 |
| 47 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.51426154 |
| 48 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48427399 |
| 49 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.47159605 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.43577076 |
| 51 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.43135766 |
| 52 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41879370 |
| 53 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39396769 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.38958966 |
| 55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.38540171 |
| 56 | KDM2B_26808549_Chip-Seq_K562_Human | 1.36712072 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.36703476 |
| 58 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.36055986 |
| 59 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.35126904 |
| 60 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.32510128 |
| 61 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.32426360 |
| 62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.32359097 |
| 63 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.30543151 |
| 64 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.29225445 |
| 65 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.28745536 |
| 66 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.27217084 |
| 67 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.27125790 |
| 68 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26783897 |
| 69 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.26225622 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26193334 |
| 71 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.25882658 |
| 72 | AR_19668381_ChIP-Seq_PC3_Human | 1.25530852 |
| 73 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24522553 |
| 74 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.22142265 |
| 75 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21666759 |
| 76 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.21344720 |
| 77 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.20238069 |
| 78 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19771682 |
| 79 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.19515710 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18333583 |
| 81 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16685089 |
| 82 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.16335994 |
| 83 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.15651426 |
| 84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15618179 |
| 85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.15376662 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14791452 |
| 87 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14572654 |
| 88 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.13598813 |
| 89 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12413583 |
| 90 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.12375985 |
| 91 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10224671 |
| 92 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.09906660 |
| 93 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09284759 |
| 94 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08818754 |
| 95 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.08698089 |
| 96 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08221681 |
| 97 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.08199507 |
| 98 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07875191 |
| 99 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.07643308 |
| 100 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.07594044 |
| 101 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05761433 |
| 102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05703248 |
| 103 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05399344 |
| 104 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.04928176 |
| 105 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.04672470 |
| 106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04424216 |
| 107 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03940676 |
| 108 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03589595 |
| 109 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03589595 |
| 110 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03549208 |
| 111 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.03216774 |
| 112 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02011670 |
| 113 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01925326 |
| 114 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01762800 |
| 115 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.01544969 |
| 116 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.01425884 |
| 117 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00980459 |
| 118 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00481462 |
| 119 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.00478695 |
| 120 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99987536 |
| 121 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.99845074 |
| 122 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98989890 |
| 123 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.98949394 |
| 124 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98745646 |
| 125 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98685874 |
| 126 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.98674756 |
| 127 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.98265028 |
| 128 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94901994 |
| 129 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94202544 |
| 130 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.94164471 |
| 131 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90601983 |
| 132 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.90543151 |
| 133 | TCF4_23295773_ChIP-Seq_U87_Human | 0.88842268 |
| 134 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88515166 |
| 135 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.88456558 |
| 136 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87598457 |
| 137 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.87015094 |
| 138 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.86909177 |
| 139 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.85606130 |
| 140 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.83929294 |
| 141 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.83746367 |
| 142 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.83720159 |
| 143 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.82278206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.28887021 |
| 2 | MP0000751_myopathy | 4.45345765 |
| 3 | * MP0004084_abnormal_cardiac_muscle | 4.35865754 |
| 4 | MP0003646_muscle_fatigue | 4.27285620 |
| 5 | * MP0004215_abnormal_myocardial_fiber | 4.14745442 |
| 6 | * MP0004036_abnormal_muscle_relaxation | 3.30770357 |
| 7 | MP0005330_cardiomyopathy | 3.18232927 |
| 8 | MP0000749_muscle_degeneration | 2.91896509 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.82983149 |
| 10 | MP0003137_abnormal_impulse_conducting | 2.71194511 |
| 11 | * MP0002972_abnormal_cardiac_muscle | 2.63557287 |
| 12 | * MP0004087_abnormal_muscle_fiber | 2.51937501 |
| 13 | MP0004145_abnormal_muscle_electrophysio | 2.42942582 |
| 14 | MP0005451_abnormal_body_composition | 2.29729416 |
| 15 | * MP0005620_abnormal_muscle_contractility | 2.26510595 |
| 16 | MP0002909_abnormal_adrenal_gland | 2.24020726 |
| 17 | MP0004130_abnormal_muscle_cell | 2.23986860 |
| 18 | * MP0004085_abnormal_heartbeat | 2.21471386 |
| 19 | MP0004510_myositis | 2.13603274 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.12506213 |
| 21 | * MP0004484_altered_response_of | 2.03630527 |
| 22 | * MP0010630_abnormal_cardiac_muscle | 2.01489144 |
| 23 | * MP0001544_abnormal_cardiovascular_syste | 2.00992422 |
| 24 | * MP0005385_cardiovascular_system_phenoty | 2.00992422 |
| 25 | MP0002106_abnormal_muscle_physiology | 2.00427361 |
| 26 | * MP0008775_abnormal_heart_ventricle | 1.99832007 |
| 27 | MP0002269_muscular_atrophy | 1.98431891 |
| 28 | MP0000733_abnormal_muscle_development | 1.93703189 |
| 29 | MP0000750_abnormal_muscle_regeneration | 1.91078211 |
| 30 | MP0005409_darkened_coat_color | 1.85971113 |
| 31 | MP0004233_abnormal_muscle_weight | 1.85870437 |
| 32 | MP0008438_abnormal_cutaneous_collagen | 1.84382339 |
| 33 | MP0003635_abnormal_synaptic_transmissio | 1.83959451 |
| 34 | MP0000747_muscle_weakness | 1.82890371 |
| 35 | * MP0006138_congestive_heart_failure | 1.79620328 |
| 36 | MP0004272_abnormal_basement_membrane | 1.76838228 |
| 37 | MP0004270_analgesia | 1.74476630 |
| 38 | MP0005369_muscle_phenotype | 1.66390091 |
| 39 | MP0000759_abnormal_skeletal_muscle | 1.58014293 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.52562378 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.51488561 |
| 42 | MP0002234_abnormal_pharynx_morphology | 1.46549588 |
| 43 | MP0004043_abnormal_pH_regulation | 1.45975496 |
| 44 | MP0003221_abnormal_cardiomyocyte_apopto | 1.40208506 |
| 45 | MP0003283_abnormal_digestive_organ | 1.39494426 |
| 46 | MP0009046_muscle_twitch | 1.37324198 |
| 47 | MP0009745_abnormal_behavioral_response | 1.33297588 |
| 48 | MP0002063_abnormal_learning/memory/cond | 1.31190449 |
| 49 | MP0002877_abnormal_melanocyte_morpholog | 1.27394910 |
| 50 | MP0003941_abnormal_skin_development | 1.27216475 |
| 51 | MP0002127_abnormal_cardiovascular_syste | 1.26636714 |
| 52 | MP0008961_abnormal_basal_metabolism | 1.24673766 |
| 53 | MP0002064_seizures | 1.22755991 |
| 54 | MP0008569_lethality_at_weaning | 1.22692230 |
| 55 | MP0002822_catalepsy | 1.21544739 |
| 56 | MP0003091_abnormal_cell_migration | 1.19774932 |
| 57 | MP0003880_abnormal_central_pattern | 1.19392121 |
| 58 | MP0005623_abnormal_meninges_morphology | 1.15985665 |
| 59 | MP0005275_abnormal_skin_tensile | 1.13450596 |
| 60 | MP0002272_abnormal_nervous_system | 1.10854469 |
| 61 | MP0000762_abnormal_tongue_morphology | 1.10355729 |
| 62 | MP0005666_abnormal_adipose_tissue | 1.10062588 |
| 63 | MP0010352_gastrointestinal_tract_polyps | 1.08130525 |
| 64 | MP0001849_ear_inflammation | 1.08023494 |
| 65 | MP0005076_abnormal_cell_differentiation | 1.07260513 |
| 66 | MP0003329_amyloid_beta_deposits | 1.04228505 |
| 67 | MP0002572_abnormal_emotion/affect_behav | 1.02089786 |
| 68 | MP0000003_abnormal_adipose_tissue | 1.01721321 |
| 69 | MP0002896_abnormal_bone_mineralization | 0.99710413 |
| 70 | MP0006036_abnormal_mitochondrial_physio | 0.98844539 |
| 71 | MP0005375_adipose_tissue_phenotype | 0.97631488 |
| 72 | MP0001348_abnormal_lacrimal_gland | 0.97523264 |
| 73 | MP0001440_abnormal_grooming_behavior | 0.96715289 |
| 74 | MP0001661_extended_life_span | 0.96327950 |
| 75 | MP0004858_abnormal_nervous_system | 0.94928068 |
| 76 | MP0002734_abnormal_mechanical_nocicepti | 0.92878668 |
| 77 | * MP0000266_abnormal_heart_morphology | 0.91135080 |
| 78 | MP0002332_abnormal_exercise_endurance | 0.90587953 |
| 79 | * MP0005386_behavior/neurological_phenoty | 0.89525853 |
| 80 | * MP0004924_abnormal_behavior | 0.89525853 |
| 81 | MP0000537_abnormal_urethra_morphology | 0.86763460 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 0.85587258 |
| 83 | MP0001486_abnormal_startle_reflex | 0.82723638 |
| 84 | * MP0003828_pulmonary_edema | 0.82419426 |
| 85 | MP0001958_emphysema | 0.82039870 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.81700902 |
| 87 | MP0004185_abnormal_adipocyte_glucose | 0.80687318 |
| 88 | MP0009672_abnormal_birth_weight | 0.79357388 |
| 89 | MP0005535_abnormal_body_temperature | 0.79049550 |
| 90 | MP0003045_fibrosis | 0.77847426 |
| 91 | MP0003705_abnormal_hypodermis_morpholog | 0.75513184 |
| 92 | MP0002108_abnormal_muscle_morphology | 0.75084458 |
| 93 | * MP0002067_abnormal_sensory_capabilities | 0.74904401 |
| 94 | MP0003633_abnormal_nervous_system | 0.74423055 |
| 95 | MP0000534_abnormal_ureter_morphology | 0.73721163 |
| 96 | MP0005023_abnormal_wound_healing | 0.73622477 |
| 97 | MP0005503_abnormal_tendon_morphology | 0.72988131 |
| 98 | * MP0000230_abnormal_systemic_arterial | 0.72139407 |
| 99 | MP0000767_abnormal_smooth_muscle | 0.71870339 |
| 100 | MP0009384_cardiac_valve_regurgitation | 0.71629531 |
| 101 | MP0001346_abnormal_lacrimal_gland | 0.70868202 |
| 102 | MP0010368_abnormal_lymphatic_system | 0.70447042 |
| 103 | MP0002249_abnormal_larynx_morphology | 0.69987740 |
| 104 | MP0001970_abnormal_pain_threshold | 0.69764753 |
| 105 | MP0003567_abnormal_fetal_cardiomyocyte | 0.69641811 |
| 106 | MP0002971_abnormal_brown_adipose | 0.69507243 |
| 107 | MP0005670_abnormal_white_adipose | 0.68985393 |
| 108 | * MP0000579_abnormal_nail_morphology | 0.68487017 |
| 109 | MP0002089_abnormal_postnatal_growth/wei | 0.68103950 |
| 110 | MP0002060_abnormal_skin_morphology | 0.67934399 |
| 111 | MP0001501_abnormal_sleep_pattern | 0.66991207 |
| 112 | MP0002733_abnormal_thermal_nociception | 0.66782312 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.66326076 |
| 114 | * MP0002128_abnormal_blood_circulation | 0.66302733 |
| 115 | MP0001968_abnormal_touch/_nociception | 0.65880125 |
| 116 | MP0005257_abnormal_intraocular_pressure | 0.65873391 |
| 117 | MP0002735_abnormal_chemical_nociception | 0.65823206 |
| 118 | MP0004811_abnormal_neuron_physiology | 0.65379360 |
| 119 | MP0002796_impaired_skin_barrier | 0.65235592 |
| 120 | MP0003950_abnormal_plasma_membrane | 0.65137472 |
| 121 | MP0001299_abnormal_eye_distance/ | 0.63911073 |
| 122 | * MP0002066_abnormal_motor_capabilities/c | 0.63456629 |
| 123 | * MP0005165_increased_susceptibility_to | 0.62341441 |
| 124 | MP0003634_abnormal_glial_cell | 0.62236332 |
| 125 | MP0003879_abnormal_hair_cell | 0.60954056 |
| 126 | MP0005167_abnormal_blood-brain_barrier | 0.60016076 |
| 127 | MP0006035_abnormal_mitochondrial_morpho | 0.58758502 |
| 128 | MP0000678_abnormal_parathyroid_gland | 0.57735880 |
| 129 | MP0002184_abnormal_innervation | 0.57662444 |
| 130 | MP0010030_abnormal_orbit_morphology | 0.56694813 |
| 131 | MP0002925_abnormal_cardiovascular_devel | 0.56517203 |
| 132 | MP0000566_synostosis | 0.55640784 |
| 133 | MP0003279_aneurysm | 0.55195137 |
| 134 | MP0000955_abnormal_spinal_cord | 0.54372798 |
| 135 | MP0005423_abnormal_somatic_nervous | 0.53780376 |
| 136 | MP0003566_abnormal_cell_adhesion | 0.53213476 |
| 137 | MP0003122_maternal_imprinting | 0.51892923 |
| 138 | MP0002557_abnormal_social/conspecific_i | 0.51627189 |
| 139 | MP0005266_abnormal_metabolism | 0.50794782 |
| 140 | MP0000462_abnormal_digestive_system | 0.50764987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.39339246 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.89486948 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 5.87981617 |
| 4 | Nemaline bodies (HP:0003798) | 5.81821890 |
| 5 | Ventricular tachycardia (HP:0004756) | 5.47435098 |
| 6 | Atrial fibrillation (HP:0005110) | 5.41461800 |
| 7 | Primary atrial arrhythmia (HP:0001692) | 5.11834090 |
| 8 | Bundle branch block (HP:0011710) | 5.03518300 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 5.00594479 |
| 10 | Syncope (HP:0001279) | 4.94802622 |
| 11 | Supraventricular tachycardia (HP:0004755) | 4.87646366 |
| 12 | Supraventricular arrhythmia (HP:0005115) | 4.78526688 |
| 13 | Exercise-induced myalgia (HP:0003738) | 4.65365885 |
| 14 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.52526012 |
| 15 | Prolonged QT interval (HP:0001657) | 4.46254519 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 4.40549618 |
| 17 | Ventricular fibrillation (HP:0001663) | 4.39488474 |
| 18 | Abnormality of the calf musculature (HP:0001430) | 4.34076015 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 4.27402658 |
| 20 | Distal lower limb muscle weakness (HP:0009053) | 4.22985549 |
| 21 | Muscle fiber splitting (HP:0003555) | 4.12168634 |
| 22 | Hyporeflexia of lower limbs (HP:0002600) | 4.08865206 |
| 23 | Lipoatrophy (HP:0100578) | 4.01731945 |
| 24 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.99369572 |
| 25 | Subaortic stenosis (HP:0001682) | 3.99369572 |
| 26 | Ventricular arrhythmia (HP:0004308) | 3.87975558 |
| 27 | Heart block (HP:0012722) | 3.79356473 |
| 28 | Myoglobinuria (HP:0002913) | 3.79262663 |
| 29 | Atrioventricular block (HP:0001678) | 3.65364863 |
| 30 | Abnormal atrioventricular conduction (HP:0005150) | 3.54628736 |
| 31 | Palpitations (HP:0001962) | 3.54131556 |
| 32 | Asymmetric septal hypertrophy (HP:0001670) | 3.43869967 |
| 33 | Dilated cardiomyopathy (HP:0001644) | 3.40873666 |
| 34 | Abnormal EKG (HP:0003115) | 3.36014070 |
| 35 | EMG: myopathic abnormalities (HP:0003458) | 3.34658510 |
| 36 | Myopathic facies (HP:0002058) | 3.30288686 |
| 37 | Dysmetric saccades (HP:0000641) | 3.21157101 |
| 38 | Ketoacidosis (HP:0001993) | 3.12565099 |
| 39 | Difficulty running (HP:0009046) | 3.02824953 |
| 40 | Myotonia (HP:0002486) | 3.02171919 |
| 41 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.98238289 |
| 42 | Round ear (HP:0100830) | 2.91291988 |
| 43 | Distal arthrogryposis (HP:0005684) | 2.82252617 |
| 44 | Increased connective tissue (HP:0009025) | 2.74574531 |
| 45 | Hypoglycemic coma (HP:0001325) | 2.72457112 |
| 46 | Pheochromocytoma (HP:0002666) | 2.70679298 |
| 47 | Left ventricular hypertrophy (HP:0001712) | 2.70260284 |
| 48 | Visual hallucinations (HP:0002367) | 2.60789223 |
| 49 | Focal motor seizures (HP:0011153) | 2.59208593 |
| 50 | Spinal rigidity (HP:0003306) | 2.58660900 |
| 51 | Rimmed vacuoles (HP:0003805) | 2.54023021 |
| 52 | Protrusio acetabuli (HP:0003179) | 2.53113312 |
| 53 | Ulnar deviation of the wrist (HP:0003049) | 2.51858695 |
| 54 | Difficulty climbing stairs (HP:0003551) | 2.46157951 |
| 55 | Increased variability in muscle fiber diameter (HP:0003557) | 2.39379919 |
| 56 | Large for gestational age (HP:0001520) | 2.38841552 |
| 57 | Neuroendocrine neoplasm (HP:0100634) | 2.26860564 |
| 58 | Calcaneovalgus deformity (HP:0001848) | 2.23259635 |
| 59 | Hamartoma of the eye (HP:0010568) | 2.17677766 |
| 60 | Areflexia of lower limbs (HP:0002522) | 2.17445797 |
| 61 | Rhabdomyolysis (HP:0003201) | 2.13691405 |
| 62 | Limb-girdle muscle atrophy (HP:0003797) | 2.13433951 |
| 63 | Focal seizures (HP:0007359) | 2.12856789 |
| 64 | Frequent falls (HP:0002359) | 2.12740938 |
| 65 | Obstructive sleep apnea (HP:0002870) | 2.12388565 |
| 66 | Arterial tortuosity (HP:0005116) | 2.10722162 |
| 67 | Hyperglycemia (HP:0003074) | 2.09968283 |
| 68 | EMG: neuropathic changes (HP:0003445) | 2.07367467 |
| 69 | Generalized muscle weakness (HP:0003324) | 2.07228216 |
| 70 | Testicular atrophy (HP:0000029) | 2.06230156 |
| 71 | Sudden cardiac death (HP:0001645) | 2.04164683 |
| 72 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.03313644 |
| 73 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.03259587 |
| 74 | Myokymia (HP:0002411) | 2.02937520 |
| 75 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.02374702 |
| 76 | Premature rupture of membranes (HP:0001788) | 2.00181621 |
| 77 | Vascular tortuosity (HP:0004948) | 1.99849605 |
| 78 | Lower limb amyotrophy (HP:0007210) | 1.98589200 |
| 79 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.98371676 |
| 80 | Action tremor (HP:0002345) | 1.96033487 |
| 81 | Dysdiadochokinesis (HP:0002075) | 1.95883091 |
| 82 | Abnormal social behavior (HP:0012433) | 1.95058004 |
| 83 | Impaired social interactions (HP:0000735) | 1.95058004 |
| 84 | Progressive muscle weakness (HP:0003323) | 1.94729732 |
| 85 | Ketosis (HP:0001946) | 1.93234382 |
| 86 | Poor eye contact (HP:0000817) | 1.92433478 |
| 87 | Rapidly progressive (HP:0003678) | 1.91831607 |
| 88 | Athetosis (HP:0002305) | 1.91177394 |
| 89 | Conjunctival hamartoma (HP:0100780) | 1.89128280 |
| 90 | Cerebral aneurysm (HP:0004944) | 1.88041300 |
| 91 | Deformed tarsal bones (HP:0008119) | 1.87398511 |
| 92 | Central scotoma (HP:0000603) | 1.85965775 |
| 93 | Bulbar palsy (HP:0001283) | 1.85829822 |
| 94 | * Palmoplantar keratoderma (HP:0000982) | 1.84817743 |
| 95 | Distal lower limb amyotrophy (HP:0008944) | 1.84000039 |
| 96 | Hyperacusis (HP:0010780) | 1.83014062 |
| 97 | Achilles tendon contracture (HP:0001771) | 1.82170899 |
| 98 | Atrophic scars (HP:0001075) | 1.81432960 |
| 99 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.80881652 |
| 100 | Abnormality of the calcaneus (HP:0008364) | 1.80265631 |
| 101 | Abnormality of the foot musculature (HP:0001436) | 1.80222159 |
| 102 | Proximal amyotrophy (HP:0007126) | 1.79320690 |
| 103 | Lymphangioma (HP:0100764) | 1.79124688 |
| 104 | Neck muscle weakness (HP:0000467) | 1.78610679 |
| 105 | Hypoplastic ischia (HP:0003175) | 1.78348079 |
| 106 | Type 1 muscle fiber predominance (HP:0003803) | 1.77563444 |
| 107 | Anxiety (HP:0000739) | 1.76392917 |
| 108 | Resting tremor (HP:0002322) | 1.76155923 |
| 109 | Congestive heart failure (HP:0001635) | 1.73591620 |
| 110 | Fragile skin (HP:0001030) | 1.73352169 |
| 111 | Scapular winging (HP:0003691) | 1.73220788 |
| 112 | Bradycardia (HP:0001662) | 1.73018146 |
| 113 | Aortic aneurysm (HP:0004942) | 1.71313175 |
| 114 | Distal upper limb amyotrophy (HP:0007149) | 1.70860922 |
| 115 | Upper limb amyotrophy (HP:0009129) | 1.70860922 |
| 116 | Ragged-red muscle fibers (HP:0003200) | 1.70382172 |
| 117 | Hip contracture (HP:0003273) | 1.70312639 |
| 118 | Gowers sign (HP:0003391) | 1.70034306 |
| 119 | Muscle stiffness (HP:0003552) | 1.69834633 |
| 120 | Aneurysm (HP:0002617) | 1.69521418 |
| 121 | Foot dorsiflexor weakness (HP:0009027) | 1.69501508 |
| 122 | Hypoglycemic seizures (HP:0002173) | 1.68693799 |
| 123 | Slender build (HP:0001533) | 1.68004365 |
| 124 | Neoplasm of the adrenal gland (HP:0100631) | 1.67803964 |
| 125 | Broad metatarsal (HP:0001783) | 1.67716852 |
| 126 | Hyperkalemia (HP:0002153) | 1.67609225 |
| 127 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.64731672 |
| 128 | Shallow orbits (HP:0000586) | 1.64721430 |
| 129 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.63202801 |
| 130 | Generalized tonic-clonic seizures (HP:0002069) | 1.61773939 |
| 131 | Abnormality of the Achilles tendon (HP:0005109) | 1.61765818 |
| 132 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.61469580 |
| 133 | Back pain (HP:0003418) | 1.60621707 |
| 134 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.59960630 |
| 135 | Metatarsus adductus (HP:0001840) | 1.59729741 |
| 136 | Postural instability (HP:0002172) | 1.58940937 |
| 137 | Papilledema (HP:0001085) | 1.58532612 |
| 138 | Tinnitus (HP:0000360) | 1.57430614 |
| 139 | Limb-girdle muscle weakness (HP:0003325) | 1.57401607 |
| 140 | Abnormality of the tricuspid valve (HP:0001702) | 1.57325849 |
| 141 | Muscular dystrophy (HP:0003560) | 1.56496813 |
| 142 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.56057320 |
| 143 | Steppage gait (HP:0003376) | 1.55770802 |
| 144 | Ulnar bowing (HP:0003031) | 1.54597319 |
| 145 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.52001413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 3.75084404 |
| 2 | LMTK2 | 3.21374864 |
| 3 | PHKG2 | 3.06482712 |
| 4 | PHKG1 | 3.06482712 |
| 5 | OBSCN | 2.93563939 |
| 6 | TRIB3 | 2.84443621 |
| 7 | EEF2K | 2.64985826 |
| 8 | DMPK | 2.63870720 |
| 9 | PKN2 | 2.63386195 |
| 10 | PDK3 | 2.46213214 |
| 11 | PDK4 | 2.46213214 |
| 12 | MYLK | 2.18447653 |
| 13 | NTRK3 | 2.15146420 |
| 14 | CDK12 | 2.13888155 |
| 15 | PRKD3 | 2.13141090 |
| 16 | INSRR | 1.85067917 |
| 17 | MAP3K4 | 1.81271385 |
| 18 | NEK1 | 1.78864186 |
| 19 | MAP3K9 | 1.75409543 |
| 20 | PRPF4B | 1.72591572 |
| 21 | EPHA4 | 1.70713893 |
| 22 | RIPK1 | 1.70064938 |
| 23 | PAK3 | 1.67857483 |
| 24 | SMG1 | 1.56963098 |
| 25 | PINK1 | 1.52816601 |
| 26 | PAK6 | 1.48906163 |
| 27 | SIK1 | 1.48643874 |
| 28 | STK38 | 1.47493938 |
| 29 | CDC42BPA | 1.46312577 |
| 30 | PIK3CA | 1.45189194 |
| 31 | KSR2 | 1.42643983 |
| 32 | MST1R | 1.41608085 |
| 33 | CAMKK1 | 1.35277901 |
| 34 | PDGFRA | 1.34839854 |
| 35 | EPHA2 | 1.29724678 |
| 36 | TRPM7 | 1.24686580 |
| 37 | PDK2 | 1.24298593 |
| 38 | MUSK | 1.23365759 |
| 39 | WNK1 | 1.18979323 |
| 40 | MARK1 | 1.18707729 |
| 41 | WNK4 | 1.18033568 |
| 42 | PRKD1 | 1.17995413 |
| 43 | MAP3K13 | 1.14311503 |
| 44 | MET | 1.13787595 |
| 45 | MAP2K4 | 1.13529846 |
| 46 | MTOR | 1.13187776 |
| 47 | ARAF | 1.10660099 |
| 48 | DAPK2 | 1.10488208 |
| 49 | PRKCH | 1.10380002 |
| 50 | FGFR4 | 1.09274666 |
| 51 | NTRK1 | 1.08560965 |
| 52 | CAMKK2 | 1.08096621 |
| 53 | STK24 | 1.07460465 |
| 54 | MINK1 | 1.07283789 |
| 55 | TIE1 | 1.07207500 |
| 56 | RET | 1.05312325 |
| 57 | MAPKAPK3 | 1.01577100 |
| 58 | MAP3K7 | 1.00724414 |
| 59 | ERN1 | 0.96579335 |
| 60 | CAMK1D | 0.95640433 |
| 61 | NEK9 | 0.93432871 |
| 62 | * CAMK2D | 0.93079210 |
| 63 | MAP3K2 | 0.91518016 |
| 64 | LIMK1 | 0.88115007 |
| 65 | PRKAA1 | 0.84858986 |
| 66 | BCKDK | 0.83496290 |
| 67 | CAMK1 | 0.83069010 |
| 68 | ROCK1 | 0.82961243 |
| 69 | MAP3K1 | 0.81484072 |
| 70 | UHMK1 | 0.81359035 |
| 71 | CAMK4 | 0.80319390 |
| 72 | * CAMK2A | 0.79693749 |
| 73 | MOS | 0.78388553 |
| 74 | EPHB1 | 0.77156618 |
| 75 | LATS2 | 0.76495052 |
| 76 | SGK3 | 0.76081089 |
| 77 | PDPK1 | 0.76000699 |
| 78 | DDR2 | 0.74040984 |
| 79 | CDK5 | 0.73805625 |
| 80 | TAOK1 | 0.73745889 |
| 81 | MAP3K5 | 0.73180242 |
| 82 | MAP3K10 | 0.71914213 |
| 83 | PDK1 | 0.70509665 |
| 84 | ALK | 0.69411821 |
| 85 | NTRK2 | 0.69308605 |
| 86 | PTK2B | 0.69197858 |
| 87 | CAMK1G | 0.68798223 |
| 88 | PIK3CG | 0.68326867 |
| 89 | ILK | 0.68263495 |
| 90 | STK11 | 0.67442381 |
| 91 | KSR1 | 0.66973922 |
| 92 | PAK2 | 0.65468592 |
| 93 | PTK6 | 0.65338969 |
| 94 | FER | 0.65319081 |
| 95 | AKT2 | 0.65049945 |
| 96 | MAP2K7 | 0.64440042 |
| 97 | PRKCE | 0.63799598 |
| 98 | GRK7 | 0.63638910 |
| 99 | MAPK12 | 0.62757642 |
| 100 | MAP3K6 | 0.61614058 |
| 101 | DAPK3 | 0.59908850 |
| 102 | MAP2K3 | 0.59572829 |
| 103 | ICK | 0.58757395 |
| 104 | MAPK10 | 0.58100132 |
| 105 | SGK1 | 0.57832222 |
| 106 | ROCK2 | 0.57448987 |
| 107 | IRAK3 | 0.56807436 |
| 108 | TESK1 | 0.56224250 |
| 109 | MAP2K1 | 0.55831521 |
| 110 | SGK2 | 0.54751823 |
| 111 | TYRO3 | 0.54174536 |
| 112 | MAPK11 | 0.50979276 |
| 113 | SCYL2 | 0.49921524 |
| 114 | PRKAA2 | 0.49780374 |
| 115 | PRKACG | 0.48418596 |
| 116 | HIPK2 | 0.47822069 |
| 117 | MAPK7 | 0.47548456 |
| 118 | AKT3 | 0.47227701 |
| 119 | MARK2 | 0.47063964 |
| 120 | SGK223 | 0.46996767 |
| 121 | SGK494 | 0.46996767 |
| 122 | LATS1 | 0.46049218 |
| 123 | PRKACB | 0.45121896 |
| 124 | RPS6KB2 | 0.44906318 |
| 125 | * CAMK2G | 0.44680322 |
| 126 | GRK5 | 0.44630422 |
| 127 | * RPS6KA3 | 0.44619092 |
| 128 | FGFR3 | 0.44430507 |
| 129 | PRKACA | 0.43505101 |
| 130 | RIPK4 | 0.43488295 |
| 131 | RAF1 | 0.40179667 |
| 132 | PAK4 | 0.39901783 |
| 133 | PRKCG | 0.39374076 |
| 134 | PDGFRB | 0.39166607 |
| 135 | PKN1 | 0.38425584 |
| 136 | BRAF | 0.38083349 |
| 137 | RPS6KL1 | 0.37177298 |
| 138 | RPS6KC1 | 0.37177298 |
| 139 | PNCK | 0.36934325 |
| 140 | BRD4 | 0.36628513 |
| 141 | PTK2 | 0.35836646 |
| 142 | RPS6KA2 | 0.35432279 |
| 143 | MAPKAPK5 | 0.35399829 |
| 144 | ERBB4 | 0.33840409 |
| 145 | PLK2 | 0.32221279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.85664194 |
| 2 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.83302231 |
| 3 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.76821012 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.47135030 |
| 5 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.42978667 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.29563278 |
| 7 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.15808147 |
| 8 | Insulin secretion_Homo sapiens_hsa04911 | 2.01399622 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.84703395 |
| 10 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.78844018 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.78524084 |
| 12 | * Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.76516093 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.74422279 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 1.49550607 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.49219306 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.49123838 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.48529500 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.47716834 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.47351194 |
| 20 | Adherens junction_Homo sapiens_hsa04520 | 1.45625039 |
| 21 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.44420303 |
| 22 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.40779244 |
| 23 | Nicotine addiction_Homo sapiens_hsa05033 | 1.40204727 |
| 24 | Morphine addiction_Homo sapiens_hsa05032 | 1.39716614 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.38657771 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.38217205 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.37965793 |
| 28 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.36351549 |
| 29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.35189386 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.34033034 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.28392879 |
| 32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.28024077 |
| 33 | Taste transduction_Homo sapiens_hsa04742 | 1.25723393 |
| 34 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.24334160 |
| 35 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.24161977 |
| 36 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.24021090 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21138047 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.17315203 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15970004 |
| 40 | Parkinsons disease_Homo sapiens_hsa05012 | 1.10324265 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.09919394 |
| 42 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.07635850 |
| 43 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.07120366 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04322139 |
| 45 | Amoebiasis_Homo sapiens_hsa05146 | 1.04246004 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.03965728 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 1.03606380 |
| 48 | Insulin resistance_Homo sapiens_hsa04931 | 1.03525572 |
| 49 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.02877496 |
| 50 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02379977 |
| 51 | Gap junction_Homo sapiens_hsa04540 | 1.01808853 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00582517 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.99344705 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97776349 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.96728571 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96719186 |
| 57 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.96144174 |
| 58 | Cocaine addiction_Homo sapiens_hsa05030 | 0.96063519 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95569143 |
| 60 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.95529516 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94703060 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94234630 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94171251 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93180966 |
| 65 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.92327238 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90757635 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90042723 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.87462113 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.85192885 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.81640157 |
| 71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.81127181 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80686882 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80363632 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80047700 |
| 75 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79292419 |
| 76 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.78953675 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78846222 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78275161 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 0.77689648 |
| 80 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.77395622 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76402072 |
| 82 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76262356 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76121008 |
| 84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.76062069 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.75084826 |
| 86 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73376757 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71532472 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70778286 |
| 89 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68339576 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.67710159 |
| 91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67397003 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.65941292 |
| 93 | Melanogenesis_Homo sapiens_hsa04916 | 0.65933365 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63348505 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60589544 |
| 96 | Bile secretion_Homo sapiens_hsa04976 | 0.59818083 |
| 97 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.59785326 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59404427 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59060724 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58490206 |
| 101 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58262172 |
| 102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58170648 |
| 103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57508216 |
| 104 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57285708 |
| 105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57266338 |
| 106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56331476 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55228071 |
| 108 | Tight junction_Homo sapiens_hsa04530 | 0.55074639 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54679509 |
| 110 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54610207 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54147673 |
| 112 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52930912 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.51815530 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51631655 |
| 115 | Prostate cancer_Homo sapiens_hsa05215 | 0.51236804 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51215204 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45901267 |
| 118 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.45752983 |
| 119 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44611082 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44440199 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44337644 |
| 122 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42757948 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42454144 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42389503 |
| 125 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42148890 |
| 126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40175758 |
| 127 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38101308 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37737736 |

